報價延遲最少15分鐘:2024/12/23 22:12 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.76 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.24/-0.84
|
|
企業價值
92.07M
|
| 資產負債 |
|
每股賬面淨值
1.02
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/12/23 22:12 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. |